Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Letvin: rAdenoviral & rMycobacterial Vector Immunogens |
| Strategy: | Vector vaccines (viral or bacterial) |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2009-10-20 |
| Study Made Public: | 2012-04-10 |
Title
Pilot study to assess immunogenicity of 1st generation recombinant Mycobacterial (rMyco) vaccine vectors
Description
CAVD 294 is a non-human primate study comparing different doses and routes in BCG/Ad5 prime/boost regimens. A follow up boost study (CAVD 267) was performed.
Sign in to see full information about this study and to download study data.
Products
rAd5-SIV rBCG PasteurIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.